$25.0M
sold in all offerings
Gossamer Bio, Inc. is a corporation based in San Diego, CA in the Biotechnology industry group. From September 4, 2026 to September 4, 2026 it filed 1 private fundraising filing for 1 offering and reported $25 million sold in all. It is a listed company (GOSS).
Updated October 10, 2026 · newest filing Sep 4, 2026
Amount sold
$25.0M
All offerings, newest filing of each
Offered
$150.0M
Total amount sought
Offerings
1
1 filing with amendments
Newest offering
$25.0M
Sold, first filed Sep 4, 2026
Investors
38
In the newest offering
Min. investment
-
In the newest offering
Facts
- Type
- Corporation
- Place
- San Diego, CA
- Industry group
- Biotechnology
- Listed
- GOSS
- First filing
- September 4, 2026
- Newest filing
- September 4, 2026
- Exemptions
- 506(b)
Offerings
1 offering, newest first, each at its newest filing
| First filed | Amount sold | Offered | Investors | Min. investment | Exemptions | Securities |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | $25.0M | $150.0M | 38 | - | 506(b) | Options or warrants, Securities on exercise of options |
Filing history
1 filing, newest first. An amendment updates an earlier offering.
| Filed | Kind | Amount sold | Offered | Investors |
|---|---|---|---|---|
| Sep 4, 2026 | New offering | $25.0M | $150.0M | 38 |
Related pages
Questions and answers
How much has Gossamer Bio, Inc. raised in private offerings?
$25 million sold in 1 private offering reported from Sep 4, 2026 to Sep 4, 2026, counting each offering once at its newest filing.
When did Gossamer Bio, Inc. last file about a private offering?
September 4, 2026. Its newest offering reported $25 million sold of $150 million offered to 38 investors.
Which exemption does Gossamer Bio, Inc. use?
506(b). Rule 506(b) does not allow public advertising.
Is Gossamer Bio, Inc. a listed company?
Yes, it is listed as GOSS.
These are notices that issuers file about their own private offerings, not verified results. Amounts are as stated in the filing. Official public data from private fundraising filings, updated daily. Amount sold is what the issuer had sold when it filed; the offered amount is the total it wants to raise.